Renal Cancer - Results from #5280

[Is surgical treatment ever indicated in metastatic renal cell carcinoma and if so, based on which scientific rationale?] March 28, 2017

Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial. March 28, 2017

[When is cytoreductive nephrectomy not beneficial for patients with metastatic renal cell carcinoma?] March 28, 2017

Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study. March 28, 2017

[Impact of robotic assistance on the use and the outcomes of nephron-sparing surgery: A single center experience] March 27, 2017

Renal cell carcinoma March 27, 2017

Prospective study of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced renal cell cancer March 27, 2017

Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy March 25, 2017

Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients March 25, 2017

[Management of Toxicities of Immune Checkpoint Inhibitors] March 24, 2017

Clear Cell Renal Cell Carcinoma with Intratumoral Granulomatous Reaction: A Case Report and Review of the Literature March 24, 2017

Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents March 24, 2017

Comprehensive assessment of renal tumor complexity in a large percutaneous cryoablation cohort March 23, 2017

[Nephropathy in Patients Undergoing Cancer Drug Therapy - Platinum Derivatives(Cisplatin and Carboplatin)] March 23, 2017

The Role of High Dose Interleukin-2 in the Era of Targeted Therapy March 23, 2017

Immunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma March 22, 2017

Reproducibility and interobserver agreement of the R.E.N.A.L. nephrometry score: focus on imaging features March 22, 2017

Human mass balance study and metabolite profiling of (14)C-niraparib, a novel poly(ADP-Ribose) polymerase (PARP)-1 and PARP-2 inhibitor, in patients with advanced cancer March 21, 2017

Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions March 21, 2017

Economic evaluation of nivolumab as a second-line treatment for advanced renal cell carcinoma from US and Chinese perspectives March 21, 2017

Page 265 of 456